Create a narrative

Silo Pharma Community

NasdaqCM:SILO Community

1 Narratives written by author
6 Comments on narratives written by author
172 Fair Values set on narratives written by author

CM

CMCVentures

Community Contributor

Groundbreaking therapies that could change the treatment landscape for PTSD, fibromyalgia, MS & Alzheimer’s

Key Takeaways Silo Pharma is advancing a diversified pipeline of innovative therapies aimed at major health challenges in Central Nervous System (CNS) disorders like PTSD, fibromyalgia, Alzheimer’s, and multiple sclerosis (MS). The company’s unique approach of combining traditional drugs with psychedelic-inspired therapies positions it to address significant gaps in the treatment landscape.

US$6.20

FV

89.8% undervalued

234.00%

Revenue growth p.a.

11

6

95

3 months ago